Share-based Payment Arrangement, Expense in USD of Enfusion, Inc. from Q3 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Enfusion, Inc. quarterly and annual Share-based Payment Arrangement, Expense history and change rate from Q3 2021 to 2024.
  • Enfusion, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2023 was $3,404,000, a 10.7% decline year-over-year.
  • Enfusion, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2023 was $7,458,000, a 70.2% decline year-over-year.
  • Enfusion, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $19,033,000, a 155% increase from 2023.
  • Enfusion, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7,458,000, a 70.2% decline from 2022.
  • Enfusion, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24,993,000, a 91.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Enfusion, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $7,458,000 $3,404,000 -$406,000 -11% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $7,864,000 $2,562,000 +$1,729,000 +208% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $6,135,000 $2,639,000 -$5,029,000 -66% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $11,164,000 $-1,147,000 -$13,829,000 -109% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $24,993,000 $3,810,000 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $833,000 +$833,000 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $7,668,000 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $12,682,000 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q3 2021 $0 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3

Enfusion, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $19,033,000 +$11,575,000 +155% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
2023 $7,458,000 -$17,535,000 -70% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
2022 $24,993,000 -$264,810,000 -91% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $289,803,000 01 Jan 2021 31 Dec 2021 10-K 12 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.